MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-2.83 Cr | ₹-2.52 Cr | ₹-1.88 Cr | ₹-0.50 Cr | ₹0.28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-2.83 Cr |
| Mar2024 | ₹-2.52 Cr |
| Mar2023 | ₹-1.88 Cr |
| Mar2022 | ₹-0.50 Cr |
| Mar2021 | ₹0.28 Cr |
How is Deferred Tax Assets / Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.83 Cr | Negative | |
| Mar2024 | ₹-2.52 Cr | Negative | |
| Mar2023 | ₹-1.88 Cr | Negative | |
| Mar2022 | ₹-0.50 Cr | Negative | |
| Mar2021 | ₹0.28 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹329.7 Cr | 7% | -15.1% | -54.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 7% |
-15.1% |
-54.8% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses